American Healthcare REIT Statistics
Total Valuation
AHR has a market cap or net worth of $5.77 billion. The enterprise value is $7.52 billion.
Important Dates
The next estimated earnings date is Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
AHR has 161.50 million shares outstanding. The number of shares has increased by 90.17% in one year.
| Current Share Class | 159.50M |
| Shares Outstanding | 161.50M |
| Shares Change (YoY) | +90.17% |
| Shares Change (QoQ) | +2.10% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | 88.75% |
| Float | 158.04M |
Valuation Ratios
| Price/FFO Ratio | 27.23 |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | 66.19 |
| PS Ratio | 2.44 |
| Forward PS | 2.56 |
| PB Ratio | 2.51 |
| P/TBV Ratio | 3.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 23.79 |
| PEG Ratio | 6.06 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.57 |
| EV / EBITDA | 21.33 |
| EV / EBIT | 53.56 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.80.
| Current Ratio | 1.39 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 4.72 |
| Debt / FCF | n/a |
| Interest Coverage | 1.23 |
Financial Efficiency
Return on equity (ROE) is -1.77% and return on invested capital (ROIC) is 2.06%.
| Return on Equity (ROE) | -1.77% |
| Return on Assets (ROA) | 1.91% |
| Return on Invested Capital (ROIC) | 2.06% |
| Return on Capital Employed (ROCE) | 3.39% |
| Revenue Per Employee | $18.46M |
| Profits Per Employee | -$357,228 |
| Employee Count | 114 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 86.64 |
Taxes
In the past 12 months, AHR has paid $2.04 million in taxes.
| Income Tax | 2.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +141.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +141.00% |
| 50-Day Moving Average | 33.16 |
| 200-Day Moving Average | 28.82 |
| Relative Strength Index (RSI) | 62.03 |
| Average Volume (20 Days) | 1,636,218 |
Short Selling Information
The latest short interest is 4.20 million, so 2.60% of the outstanding shares have been sold short.
| Short Interest | 4.20M |
| Short Previous Month | 7.44M |
| Short % of Shares Out | 2.60% |
| Short % of Float | 2.66% |
| Short Ratio (days to cover) | 2.45 |
Income Statement
In the last 12 months, AHR had revenue of $2.10 billion and -$40.72 million in losses. Loss per share was -$0.28.
| Revenue | 2.10B |
| Gross Profit | 366.78M |
| Operating Income | 140.36M |
| Pretax Income | -34.19M |
| Net Income | -40.72M |
| EBITDA | 352.53M |
| EBIT | 140.36M |
| Loss Per Share | -$0.28 |
Full Income StatementBalance Sheet
The company has $86.64 million in cash and $1.83 billion in debt, giving a net cash position of -$1.75 billion or -$10.81 per share.
| Cash & Cash Equivalents | 86.64M |
| Total Debt | 1.83B |
| Net Cash | -1.75B |
| Net Cash Per Share | -$10.81 |
| Equity (Book Value) | 2.30B |
| Book Value Per Share | 14.22 |
| Working Capital | 128.66M |
Full Balance SheetCash Flow
| Operating Cash Flow | 242.66M |
| Capital Expenditures | -91.94M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 17.43%, with operating and profit margins of 6.67% and -1.94%.
| Gross Margin | 17.43% |
| Operating Margin | 6.67% |
| Pretax Margin | -1.78% |
| Profit Margin | -1.94% |
| EBITDA Margin | 16.75% |
| EBIT Margin | 6.67% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.00, which amounts to a dividend yield of 2.80%.
| Dividend Per Share | $1.00 |
| Dividend Yield | 2.80% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -90.17% |
| Shareholder Yield | -87.37% |
| Earnings Yield | -0.71% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for AHR is $37.14, which is 3.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.14 |
| Price Target Difference | 3.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |